Açıklama

Study design schematic for the Beyond Ageing Project Phase 2, a double-blind randomized placebo-controlled trial evaluating omega-3 fatty acids and sertraline for depression prevention in an older adult cohort at elevated risk.

Figure 1

Flowchart

Source Paper

The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an …

Trials (2015)

PMID: 26037484

DOI: 10.1186/s13063-015-0762-6

Cite This Figure

![Figure 1: Study design schematic for the Beyond Ageing Project Phase 2, a double-blind randomized placebo-controlled trial evaluating omega-3 fatty acids and sertraline for depression prevention in an older adult cohort at elevated risk.]()

> Source: Nicole L Cockayne et al. "The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomi." *Trials*, 2015. PMID: [26037484](https://pubmed.ncbi.nlm.nih.gov/26037484/)

<figure>
  <img src="" alt="Study design schematic for the Beyond Ageing Project Phase 2, a double-blind randomized placebo-controlled trial evaluating omega-3 fatty acids and sertraline for depression prevention in an older adult cohort at elevated risk." />
  <figcaption>Figure 1. Study design schematic for the Beyond Ageing Project Phase 2, a double-blind randomized placebo-controlled trial evaluating omega-3 fatty acids and sertraline for depression prevention in an older adult cohort at elevated risk.<br>  Source: Nicole L Cockayne et al. "The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomi." <em>Trials</em>, 2015. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26037484/">26037484</a></figcaption>
</figure>

İlgili Kanıtlar

Omega-3 Fatty Acids (DHA/EPA) için Cerebrovascular Health

Derece B · 12 çalışma